| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |